CooperVision, Inc.
Clinical trials sponsored by CooperVision, Inc., explained in plain language.
A contact lens manufacturer and subsidiary of The Cooper Companies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Contact lenses that could slow nearsightedness in kids
Disease control OngoingThis study tests whether MiSight 1 Day contact lenses can slow the progression of myopia (nearsightedness) in children aged 8 to 12. Participants wear either MiSight 1 Day or standard Proclear 1 day lenses for three years, then all switch to Proclear for one year to see if the ef…
Sponsor: CooperVision, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Contact lens safety check for kids with myopia
Disease control OngoingThis study looks at the safety of MiSight 1 Day contact lenses in children aged 8 to 12 with nearsightedness (myopia). Participants wear the lenses daily for three years, and researchers track eye infections and other problems. The goal is to confirm that these lenses are safe fo…
Sponsor: CooperVision, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC